Caroline Mullis, MD is an attending physician and postdoctoral research fellow at the Montefiore Medical Center and Albert Einstein College of Medicine. She completed her internal medicine training at the Icahn School of Medicine at Mt. Sinai and her Infectious Diseases fellowship at the Montefiore Medical Center and Albert Einstein College of Medicine. Dr. Mullis is currently completing a Masters in Clinical Research Methods. Her research work focuses on improving delivery of pre-exposure prophylaxis for HIV prevention to cisgender women. In addition to her research, Dr. Mullis sees inpatient infectious diseases consults and provides HIV, PrEP and STI outpatient care at the Oval Center at Montefiore.

Dr. Madeleine R. Heldman, M.D., M.S. is an Assistant Professor of Medicine at Duke University in the Division of Infectious Diseases, where she attends on the transplant and immunocompromised host infectious diseases consult service. She graduated cum laude from Northwestern University Feinberg School of Medicine and completed her internal medicine residency at Northwestern University in Chicago, IL, USA. She completed her infectious diseases fellowship training at the University of Washington and her T32 research fellowship at the Fred Hutchinson Cancer Center. Dr. Heldman serves on the American Society of Transplantation’s Infectious Diseases Community of Practice executive committee. Her research interests focus on viral infections in immunocompromised hosts.

For example: Nate Bahr MD, MA FIDSA is an associate professor of infectious diseases at the University of Kansas City in Kansas City Kansas. Dr. Bahr is a clinical investigator funded by NIH with interests in HIV associated opportunistic infections and endemic fungi, particularly, cryptococcal meningitis, histoplasmosis, and TB meningitis. Dr. Bahr is also interested in factors influencing drug pricing in the United States. Dr. Bahr is a member of the International TB meningitis consortium and is a member of their guidelines committee. He is also a member of the panel currently constructing IDSA’s histoplasmosis guidelines and was an external reviewer for the WHO/PAHO Guidelines for the diagnosis and management of progressive disseminated histoplasmosis in HIV-infected populations published in 2020. Dr. Bahr’s work has directly influenced WHO guidelines on cryptococcal meningitis and TB meningitis and he is a fellow of the IDSA and the ACP.